Cutaneous Findings of COVID-19 Infection Related with Length of Hospital Stay: A Prospective, Multicenter Study
Turkiye Klinikleri Dermatoloji, cilt.32, sa.1, ss.56-61, 2022 (Scopus, TRDizin)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 32 Sayı: 1
- Basım Tarihi: 2022
- Doi Numarası: 10.5336/dermato.2021-86767
- Dergi Adı: Turkiye Klinikleri Dermatoloji
- Derginin Tarandığı İndeksler: Scopus, Academic Search Premier, CAB Abstracts, EMBASE, TR DİZİN (ULAKBİM)
- Sayfa Sayıları: ss.56-61
- Anahtar Kelimeler: COVID-19, dermatology, length of stay, pandemics, prognosis
- Açık Arşiv Koleksiyonu: AVESİS Açık Erişim Koleksiyonu
- Sağlık Bilimleri Üniversitesi Adresli: Evet
Özet
Objective: Coronavirus disease-2019 (COVID-19) was declared a pandemic in March 2020. As the number of cases increased, the infection emerged as a multi-systemic disease. Respiratory, cardiac, hepatic, urinary, circulatory, gastrointestinal systems and finally skin may be the target organs of COVID-19. The aim of this study was to evaluate the cutaneous signs of COVID-19 and their effect on the patients' prognosis. Material and Methods: A total of 192 hospitalized COVID-19 cases, between May 2021 to July 2021 were included in the study. The length of stay (LoS) of the patients were recorded. Hospitalization and discharge decisions and all treatments of the patients were determined at the discretion of the treating physician according to the pandemic guidelines of the Ministry of Health. Fever, fatigue, cough, dyspnea, myalgia, anosmia, and headache were considered COVID-19 symptoms. Results: Dermatological manifestations were seen in 10 cases. LoS in the group with dermatological findings was shorter than the group without dermatological findings and the difference was statistically significant between the groups. Discharge of the patients was the endpoint of the study. Conclusion: Our multicenter study suggests that patients with cutaneous findings usually do not have classical symptoms for COVID-19 and have a shorter LoS.